Evidence that does not support pyruvate kinase M2 (PKM2) - Catalyzed reaction as a rate-limiting step in cancer cell glycolysis

35Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It has been recognized that the rate-limiting function of pyruvate kinase M2 (PKM2) in glycolysis plays an important role in distributing glycolytic intermediates for anabolic and catabolic purposes in cancer cells. However, after analysis of the catalytic capacity of PKM2 relative to other glycolytic enzymes, the regulation range of PKM2 activity, metabolic flux control, and thermodynamics, we suggest that the PKM2-catalyzed reaction is not a rate-limiting step in cancer cell glycolysis. Hexokinase and phosphofructokinase 1 (PFK1), the first and third enzyme along the pathway, are rate-limiting enzymes that limit the overall glycolytic rate, whereas PKM2 and lactate dehydrogenase, the last two enzymes in the pathway, are for the fast removal of upstream intermediates to prevent the obstruction of the pathway. The argument is in accordance with the catalytic capacity of glycolytic enzymes, regulation range of enzyme activities, metabolic flux control, and thermodynamics.

Cite

CITATION STYLE

APA

Xie, J., Dai, C., & Hu, X. (2016). Evidence that does not support pyruvate kinase M2 (PKM2) - Catalyzed reaction as a rate-limiting step in cancer cell glycolysis. Journal of Biological Chemistry, 291(17), 8987–8999. https://doi.org/10.1074/jbc.M115.704825

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free